Cargando…
The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
Almost 600 million people are predicted to have diabetes mellitus (DM) by 2035. Diabetic patients suffer from increased rates of microvascular and macrovascular complications, associated with dyslipidaemia, impaired angiogenic responses to ischaemia, accelerated atherosclerosis, and inflammation. De...
Autores principales: | Wong, Nathan K. P., Nicholls, Stephen J., Tan, Joanne T. M., Bursill, Christina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032203/ https://www.ncbi.nlm.nih.gov/pubmed/29874886 http://dx.doi.org/10.3390/ijms19061680 |
Ejemplares similares
-
Exploring the Roles of CREBRF and TRIM2 in the Regulation of Angiogenesis by High-Density Lipoproteins
por: Wong, Nathan K. P., et al.
Publicado: (2018) -
The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis
por: Primer, Khalia R., et al.
Publicado: (2020) -
High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes
por: Chen, Xing, et al.
Publicado: (2017) -
The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis
por: Hourigan, Samuel T., et al.
Publicado: (2018) -
The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications
por: Solly, Emma L., et al.
Publicado: (2021)